Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
11 studies found for:    hong proton | Open Studies | Exclude Unknown
Show Display Options
Rank Status Study
1 Recruiting Early-Phase Safety of Proton Therapy Equipment
Conditions: Malignant Glioma;   Hepatocellular Carcinoma.;   Head and Neck Malignant Tumor;   Prostate Cancer
Intervention: Radiation: proton therapy
2 Recruiting Proton w/FOLFIRINOX-Losartan for Pancreatic Cancer
Condition: Pancreatic Cancer
Interventions: Drug: FOLFIRINOX;   Drug: Losartan;   Radiation: Proton Beam Radiation
3 Recruiting PPI for Prevention of Post-sphincterotomy Bleeding
Conditions: Bleeding;   ERCP
Interventions: Drug: Esomeprazole;   Other: Standard care
4 Recruiting Short Course Radiation Therapy With Proton or Photon Beam Capecitabine and Hydroxychloroquine for Resectable Pancreatic Cancer
Condition: Pancreatic Cancer
Interventions: Drug: Capecitabine;   Drug: Hydroxychloroquine;   Radiation: Proton or Photon Radiation Therapy
5 Recruiting H2RA VS PPI for the Prevention of Ulcer Bleeding Associated With Low-dose Aspirin in Patients With Very High Ulcer Risk
Condition: Peptic Ulcer Bleeding
Interventions: Drug: Rabeprazole;   Drug: Famotidine
6 Recruiting BRAVO Study for Functional Dyspepsia
Conditions: Dyspepsia;   Gastroesophageal Reflux
Interventions: Drug: Esomeprazole 20mg;   Other: Placebo
7 Recruiting FOLFIRINOX + RT for Pancreatic Cancer
Condition: Pancreatic Cancer
Interventions: Drug: FOLFIRINOX;   Drug: Capecitabine;   Radiation: Short Course Radiation;   Procedure: Surgery
8 Recruiting Early Selective Transarterial Embolization (TAE) to Severely Bleeding Peptic Ulcers After Their Initial Endoscopic Hemostasis
Conditions: Bleeding;   Peptic Ulcer;   Arterial Embolization
Interventions: Procedure: TAE;   Procedure: No TAE
9 Recruiting Second-look Endoscopy in High Risk Patients After Endoscopic Hemostasis to Their Bleeding Peptic Ulcers Improves Their Outcomes
Condition: Ulcer Bleeding
Intervention: Procedure: epinephrine injection or heater probe or hemoclips
10 Recruiting A Pilot Study of Neoadjuvant Therapy With Gemcitabine and Cisplatin in Patients With Resectable or Unresectable Intrahepatic Cholangiocarcinoma
Conditions: Unresectable Intrahepatic Cholangiocarcinoma;   Resectable Intrahepatic Cholangiocarcinoma
Interventions: Drug: Gemcitabine;   Drug: Cisplatin;   Procedure: Surgery;   Radiation: Radiation
11 Recruiting S-pantoprazole 10mg Phase III Clinical Study
Condition: Non Erosive Reflux Disease
Interventions: Drug: S-pantoprazole 10mg;   Drug: Placebo

Indicates status has not been verified in more than two years